Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Susanne Perez-Gutthann"'
Autor:
Jordi Castellsague, Susanne Perez-Gutthann, L.A. Garcia-Rodríguez, M.G. Troncon, C. Cattaruzi, L. Agostinis
Publikováno v:
Respiratory Medicine. 93(10):709-714
We characterized the population of users of inhaled long-acting β 2 -agonists in the region of Friuli-Venezia Giulia, in Italy, and assessed changes in asthma treatment and control after initiating long-acting β 2 -agonists. All residents using for
Autor:
Luis A. García-Rodríguez, Cristina Varas-Lorenzo, Alberto Duque-Oliart, Susanne Perez-Gutthann
Publikováno v:
Pharmacotherapy. 19:854-859
The risk of a newly diagnosed episode of upper gastrointestinal bleeding, acute liver and renal failure, agranulocytosis, aplastic anemia, severe skin disorders, and anaphylaxis was examined within 30 days after the first prescription for a low dose
Publikováno v:
Pharmacoepidemiology, Third Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1c7f6e407f589c4d6ef297c9f3ee874
https://doi.org/10.1002/0470842555.ch23
https://doi.org/10.1002/0470842555.ch23
Autor:
Luis A. García-Rodríguez, Susanne Perez-Gutthann, Alberto Duque-Oliart, Cristina Varas-Lorenzo
Publikováno v:
Circulation. 101(22)
Background —Epidemiological studies suggest a decreased risk of coronary heart disease (CHD) in healthy women taking hormonal replacement therapy (HRT). Whether this effect is shared by oral and transdermal preparations is unknown. Methods and Resu
Publikováno v:
Lancet (London, England). 352(9142)
related disorders requires an appropriate study design and careful interpretation of the results. We describe, briefly, the important general principles of drug epidemiological research that should be used to assess the quality and validity of studie
Autor:
Susanne Perez-Gutthann, Luis Alberto García-Rodríuez, Luisa Agostinis, Chiara Cattaruzzi, Cristina Varas-Lorenzo, Maria Grazia Troncon
Publikováno v:
American journal of epidemiology. 147(4)
The authors evaluated the risk of venous thromboembolism associated with hormone replacement therapy in a cohort of 265,431 women aged 45-79 years who did not have major risk factors for venous thromboembolism. Through review of hospital charts, 171
Publikováno v:
The American journal of medicine. 93(5)
To estimate the frequency of and examine risk factors for coronary artery disease (CAD) in patients with systemic lupus erythematosus (SLE) in a prospective longitudinal study.Patients were SLE are enrolled in The Johns Hopkins Lupus Cohort, a prospe
Publikováno v:
The American journal of medicine. 91(4)
To determine if differences in morbidity of systemic lupus erythematosus (SLE) as measured by (1) important renal disease, (2) number of hospitalizations, and (3) neurologic disease can be explained by race, socioeconomic status (SES), or measures of